EZH2 and neoplasm: Our findings, together with a previous study reporting that EZH2 supports mutp53 by enhancing its translation [34], strengthen the idea that EZH2 inhibition may help target mutp53 and compromise the cell survival of tumor cells harboring this oncogenic protein.